Age-related maculopathy - Linking aetiology and pathophysiological changes to the ischaemia hypothesis

Progress in Retinal and Eye Research

Volumn 28, Issue 1, 2009, Pages 63-86

  Feigl, Beatrix ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Age related maculopathy; Basal laminar deposits; Basal linear deposits; Bevacizumab; Complement factor H; Electroretinography; Hypoxia; Ischaemia; Ranibizumab; VEGF

Indexed keywords

VASCULOTROPIN;

CHOROID CAPILLARY LAYER; CLINICAL FEATURE; DISEASE COURSE; FAT INTAKE; GENETIC ANALYSIS; HEART FUNCTION TEST; HEMODYNAMICS; HISTOPATHOLOGY; HUMAN; HYPOXIA; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; ISCHEMIA; NOMENCLATURE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PHOTORECEPTOR; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; RISK FACTOR;

HUMANS; ISCHEMIA; MACULAR DEGENERATION; RETINAL VESSELS;

EID: 59949092983     PISSN: 13509462     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.preteyeres.2008.11.004     Document Type: Review

References (359)

1. Adler R., Curcio C., Hicks D., Price D., and Wong D. Cell death in age-related macular degeneration. Mol. Vis. 5 (1999) 31
2. Age-Related Eye Disease Study Research Group. Risk factors associated with age-related macular degeneration. A case-control study in the Age-Related Eye Disease Study: AREDS report no. 3. Ophthalmology 107 (2000) 2224-2232
3. Age-Related Eye Disease Study Research Group. The age-related eye disease study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study Report Number 6. Am. J. Ophthalmol. 132 (2001) 668-681
4. Aiba T., Alpern M., and Maaseidvaag F. The electroretinogram evoked by excitation of human foveal cones. J. Phys. 189 (1967) 43-62
5. Alder V.A., and Cringle S.J. Vitreal and retinal oxygenation. Graefe's Arch. Clin. Exp. Ophthalmol. 228 (1990) 151-157
6. Ambati J., Ambati B.K., Yoo S., Ianchulev S., and Adamis A.P. Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv. Ophthalmol. 48 (2003) 257-293
7. Arden G., and Banks J. Foveal electroretinogram as a clinical test. Br. J. Ophthalmol. 50 (1966) 740
8. Arden G.B., Sidman R.L., Arap W., and Schlingemann R. Spare the rod and spoil the eye. Br. J. Ophthalmol. 89 (2005) 764-769
9. Arden G.B., and Wolf J.E. Differential effects of light and alcohol on the electro-oculographic responses of patients with age-related macular disease. Invest. Ophthalmol. Vis. Sci. 44 (2003) 3226-3232
10. Baird P.N., Robman L.D., Richardson A.J., Dimitrov P.N., Tikellis G., McCarty C.A., and Guymer R.H. Gene-environment interaction in progression of AMD - the CFH gene, smoking and exposure to chronic infection. Hum. Mol. Genet. (2008) Epub ahead of print
11. Balslev E., Thomson H.K., Danielson L., Sheller J., and Garred P. The terminal complement complex is generated in chronic leg ulcers in the absence of protectin (CD59). APMIS 107 (1999) 997-1004
12. Barnett N.L., and Osborne N.N. Prolonged bilateral carotid artery occlusion induces electrophysiological and immunohistochemical changes to the rat retina without causing histological damage. Exp. Eye Res. 61 (1995) 83-90
13. Bashshur Z.F., Haddad Z.A., Schakal A., Jaafar R.F., Saab M., and Noureddin B.N. Intravitreal bevacizumab for treatment of neovascular age-related macular degeneration: a one-year prospective study. Am. J. Ophthalmol. (2007) 10.1016/j.ajo.2007.1009.1031
14. Bearse M.A.J., Han Y., Schneck M., and Adams A. Retinal function in normal and diabetic eyes mapped with slow flash multifocal electroretinogram. Invest. Ophthalmol. Vis. Sci. 45 (2004) 296-304
15. Beatty S., Koh H.H., Henson D., and Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv. Ophthalmol. 45 (2000) 115-132
16. Becerra P.S. Focus on molecules: pigment epithelium-derived factor (PEDF). Exp. Eye Res. 82 (2006) 739-740
17. Bhutto I.A., McLeod D.S., Hasegawa T., Kim S.Y., Merges C., Tong P., and Lutty G.A. Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration. Exp. Eye Res. 82 (2006) 99-110
18. Biersdorf W., and Diller D. Local electroretinogram in macular degeneration. Am. J. Ophthalmol. 68 (1969) 269-303
19. Bird A.C. Investigation of disease mechanisms in retinitis pigmentosa. Ophthalmol. Paed. Gen. 13 (1992) 57-66
20. Blaauwgeers H., Holtkamp G., Rutten H., Witmer A.N., Koolwijk P., Patanen A., Alitalo K., Kroon M., Kijlstra A., van Hinsberg V., and Schlingemann R. Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localisation of vascular endothelial growth factor receptors on the inner choriocapillaris. Evidence for a paracrine relation. Am. J. Pathol. 155 (1999) 412-428
21. Bora P.S., Sohn J.H., Cruz J.M., Jha P., Nishihori H., Wang Y., Kaliappan S., Kaplan H.J., and Bora N.S. Role of complement and complement membrane attack complex in laser-induced choroidal neovascularization. J. Immunol. 174 (2005) 491-497
22. Bowen R.W., Pokorny J., and Smith V.C. Isolating color mechanisms with hue substitution. Nature 285 (1980) 440
23. Brantley Jr. M.A., Edelstein S.L., King J.M., Plotzke M.R., Apte R.S., Kymes S.M., and Shields A. Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to photodynamic therapy. Eye (2008) 10.1038/eye.2008.1028
24. Bressler N.M., Bressler S.B., West S.K., Fine S.L., and Taylor H.R. The grading and prevalence of macular degeneration in Chesapeake Bay waterman. Arch. Ophthalmol. 107 (1989) 847-852
25. Brinchmann-Hansen O., and Myhre K. The effect of hypoxia upon macular recovery time in normal humans. Aviat. Space Environ. Med. 60 (1989) 1183-1186
26. Brown B., Adams A., Coletta N., and Haegerstrom-Portnoy G. Dark adaptation in age-related maculopathy. Ophthalmic Physiol. Opt. 6 (1986) 81-84
27. Brown B., and Kitchin J. Dark adaptation and the acuity/luminance response in senile macular degeneration (SMD). Am. J. Optom. Physiol. Opt. 60 (1983) 645-650
28. Brown B., and Lovie-Kitchin J. Contrast sensitivity in central and paracentral retina in age-related maculopathy. Clin. Exp. Optom. 70 (1987) 145-148
29. Brown B., and Lovie-Kitchin J. Temporal function in age related maculopathy. Clin. Exp. Optom. 70 (1987) 112-116
30. Brown B., Tobin C., Roche N., and Wolanowski A. Cone adaptation in age-related maculopathy. Am. J. Optom. Physiol. Opt. 63 (1986) 450-454
31. Brown D.M., Kaiser P.K., Michels M., Soubrane G., Heier J.S., Kim R.Y., Sy J., Schneider S., and for the ANCHOR Study Group. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N. Engl. J. Med. 355 (2006) 1432-1444
32. Bui B.V., Vingrys A., and Kalloniatis M. Correlating retinal function and amino acid immunocytochemistry following post-mortem ischemia. Exp. Eye Res. 77 (2003) 125-136
33. Cahill M.T., Banks A.D., Stinnett S.S., and Toth C.A. Vision-related quality of life in patients with bilateral severe age-related macular degeneration. Ophthalmology 112 (2005) 152-158
34. Campochiaro P. Ocular neovascularization and excessive vascular permeability. Expert Opin. Biol. Ther. 4 (2004) 1395-1402
35. Cao D., Pokorny J., Smith V.C., and Zele A.J. Rod contributions to color perception: linear with rod contrast. Vision Res. 48 (2008) 2586-2592
36. Cao D., Zele A.J., and Pokorny J. Chromatic discrimination in the presence of incremental and decremental rod pedestals. Vis. Neurosci. 25 (2008) 399-404
37. Casson R.J., Chidlow G., Wood J.P.M., and Osborne N.N. The effect of hyperglycemia on experimental retinal ischemia. Arch. Ophthalmol. 122 (2004) 361-366
38. Chen J.C., Fitzke F.W., Pauleikhoff D., and Bird A.C. Functional loss in age-related Bruch's membrane change with choroidal perfusion defect. Invest. Ophthalmol. Vis. Sci. 33 (1992) 334-340
39. Cheng A., and Vingrys A. Visual losses in early age-related maculopathy. Optom. Vis. Sci. 70 (1992) 89-96
40. Chong E.W., Sinclair A.J., and Guymer R.H. Facts on fats. Clin. Exp. Ophthalmol. 34 (2006) 464-471
41. Ciulla T.A., Harris A., and Chung H.S. Color Doppler imaging discloses reduced ocular blood flow velocities in non-exudative age-related macular degeneration. Am. J. Ophthalmol. 128 (1999) 75-80
42. Ciulla T.A., Harris A., and Martin B.J. Ocular perfusion and age-related macular degeneration. Acta Ophthalmol. Scand. 79 (2001) 108-115
43. Coats G. Forms of retinal disease with massive exudation. R. London Ophthalmic Hosp. Rep. (1908) 440-525
44. Coffey P.J., McDermott C.J., Lundh P., Pickering M.C., Sethi C., Bird A.C., Fitzke F.W., Maass A., Chem L.L., Holder G.E., Luthert P., Salt T.E., Moss S.E., and Greenwood J. Complement factor H deficiency in aged mice causes retinal abnormalities and visual function. PNAS 104 (2007) 16651-16656
45. Collins M., and Brown B. Glare recovery and its relation to other clinical findings in age related maculopathy. Clin. Vis. Sci. 4 (1989) 155-163
46. Collins M.J. Pre-age-related maculopathy and the desaturated D-15 colour vision test. Clin. Exp. Optom. 69 (1986) 223-227
47. Complications of Age-related Macular Degeneration Prevention Trial (CAPT) Research Group. Risk factors for choroidal neovascularization and geographic atrophy in the complications of age-related macular degeneration prevention trial. Ophthalmology 115 (2008) 1474-1479
48. Connolly D.M., Barbur J.L., Hosking S.L., and Moorhead I.R. Mild hypoxia impairs chromatic sensitivity in the mesopic range. Invest. Ophthalmol. 49 (2008) 820-827
49. Connolly D.M., and Hosking S.L. Aviation-related respiratory gas disturbances affect dark adaptation: a reappraisal. Vision Res. 46 (2006) 1784-1793
50. Crawford Y., and Ferrara N. VEGF inhibition: insights from preclinical and clinical studies. Cell Tissue Res. (2008) 10.1007/s00441-00008-00675-00448
51. Cringle S., Yu D.-Y., Yu P., and Su E.-N. Intraretinal oxygen consumption in the rat in vivo. Invest. Ophthalmol. Vis. Sci. 43 (2002) 1922-1927
52. Curcio A.C., Presley J.B., Millican C.L., and Medeiros N.E. Basal deposits and drusen in eyes with age-related maculopathy: evidence for solid lipid particles. Exp. Eye Res. 80 (2005) 761-775
53. Curcio C.A. Photoreceptor topography in aging and age-related maculopathy. Eye 15 (2001) 376-383
54. Curcio C.A., Medeiros N.E., and Millican L.J. Photoreceptor loss in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 37 (1996) 1236-1249
55. Curcio C.A., and Millican C.L. Basal linear deposit and large drusen are specific for early age-related maculopathy. Arch. Ophthalmol. 117 (1999) 329-339
56. Curcio C.A., Owsley C., and Jackson G.R. Spare the rods, save the cones in aging and age-related maculopathy. Invest. Ophthalmol. Vis. Sci. 41 (2000) 2015-2018
57. Curcio, C.A., Presley, J.B., Malek, G., Medeiros, N.E., Avery, D.V., Kruth, H.S., 2005. Esterified and unesterified cholesterol in drusen and basal deposits of eyes with age-related maculopathy. Exp. Eye Res. 81, 731-741.
58. D'Amore P.A. Mechanisms of retinal and choroidal neovascularisation. Invest. Ophthalmol. Vis. Sci. 35 (1994) 3974-3979
59. Delaney V.W., and Oates R.I.P. Senile macular degeneration: a preliminary study. Ann. Ophthalmol. 14 (1986) 21-24
60. Deutman A.F. Hereditary dystrophies of the central retina and choroid. In: Winkelman J.E., and Crone R.A. (Eds). Perspectives in Ophthalmology (1970), Excerpta Medica, Amsterdam (Chapter 2)
61. DeWan A., Bracken M.B., and Hoh J. Two genetic pathways for age-related macular degeneration. Curr. Opin. Genet. Dev. 17 (2007) 228-233
62. Dimitrov P.N., Guymer R.H., Zele A.J., Anderson A.J., and Vingrys A.J. Measuring rod and cone dynamics in age-related maculopathy. Invest. Ophthalmol. Vis. Sci. 49 (2008) 55-65
63. Din N.J., Newby D.E., and Flapan A.D. Omega 3 fatty acids and cardiovascular disease - fishing for a natural treatment. Br. Med. J. 328 (2004) 30-35
64. Donner K.O., and Rushton W.A. Retinal stimulation by light substitution. J. Physiol. 149 (1959) 288-302
65. Donoso L.A., Kim D., Frost A., Callahan A., and Hageman G.S. The role of inflammation in the pathogenesis of age-related macular degeneration. Surv. Ophthalmol. 51 (2006) 137-152
66. Duke-Elder S. In: Duke-Elder (Ed). System of Ophthalmology vol. 9 (1966), Kimpton, London 610
67. Eastwood M. Principles of Human Nutrition. first ed. (1997), Chapman & Hall, London
68. Edwards A.O., Ritter R., Abel K.J., Manning A., Panhuysen C., and Farrer L.A. Complement factor H polymorphism and age-related macular degeneration. Science 308 (2005) 421-424
69. Eisner A., Klein M., Zilis J., and Watkins M. Visual function and the subsequent development of exudative age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 33 (1992) 3091-3102
70. Eisner A., Stoumbos V.D., Klein M.L., and Fleming A. Relation between fundus appearance and function. Eyes whose fellow eye has exudative age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 32 (1991) 8-20
71. Elsner A.E., Burns S.A., and Weiter J.J. Cone photopigment in older subjects: decreased optical density in early age-related macular degeneration. J. Opt. Soc. Am. A 19 (2002) 215-222
72. Emerson M.V., KLauer A.K., Flaxel C.J., Wilson D.J., Francis P.J., Stout J.T., Emerson G.G., Schlesinger T.K., Nolte S.K., and Klein M.L. Intravitreal bevacizumab (Avastin) treatment of neovascular age-related macular degeneration. Retina 24 (2007) 439-444
73. Esparza-Gordillo J., Soria J.M., Buil A., Almasy L., Blangaro J., Fontcuberta J., and Rodriguez de Cordoba S. Genetic and environmental factors influencing the human factor H plasma levels. Immunogenetics 56 (2004) 77-82
74. Estévez O., and Spekreijse H. The "silent substitution" method in visual research. Vision Res. 22 (1982) 681-691
75. Evans J. Risk factors for age-related macular degeneration. Prog. Retin. Eye Res. 20 (2000) 227-253
76. Eye Disease Case-Control Study Group. Risk factors for neovascular age-related macular degeneration. Arch. Ophthalmol. 110 (1992) 1701-1708
77. Eye Disease Prevalence Research Group. Prevalence of age-related macular degeneration in the United States. Arch. Ophthalmol. 122 (2004) 564-572
78. Fallon T.J., Maxwell D., and Kohner E.M. Retinal vascular autoregulation in conditions of hyperoxia and hypoxia using the blue field entoptic phenomenon. Ophthalmology 92 (1985) 701-705
79. Falsini B., Fadda A., Iarossi G., Piccardi M., Canu D., Minnella A., Serrao S., and Scullica L. Retinal sensitivity to flicker modulation: reduced by early age-related maculopathy. Invest. Ophthalmol. Vis. Sci. 41 (2003) 1498-1506
80. Falsini B., Riva C., and Logean E. Flicker-evoked changes in human optic nerve blood flow: relationship with retinal neural activity. Invest. Ophthalmol. Vis. Sci. 43 (2002) 2309-2316
81. Feeney-Burns L., and Ellersieck M. Age-related changes in the ultrastructure of Bruch's membrane. Am. J. Ophthalmol. 100 (1985) 686-697
82. Feigl, B., Brown, B., Lovie-Kitchin, J., 2004a. Cone- and rod-mediated retinal function before and after multiple laser therapies in age-related macular degeneration. In: 2004 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO): Abstract 799.
83. Feigl B., Brown B., Lovie-Kitchin J., and Lee L. Dynamics of retinal function after multiple photodynamic therapies in age-related macular degeneration: a report of cases. Doc. Ophthalmol. 111 (2005) 135-148
84. Feigl B., Brown B., Lovie-Kitchin J., and Swann P. Postreceptoral adaptation abnormalities in early age-related maculopathy. Vis. Neurosci. 23 (2006) 863-870
85. Feigl B., Brown B., Lovie-Kitchin J., and Swann P.G. Cone-mediated multifocal electroretinogram in early age-related maculopathy and its relationships with subjective macular function tests. Curr. Eye Res. 29 (2004) 327-336
86. Feigl B., Brown B., Lovie-Kitchin J., and Swann P.G. Adaptation responses in early age-related maculopathy. Invest. Ophthalmol. Vis. Sci. 46 (2005) 4722-4727
87. Feigl B., Brown B., Lovie-Kitchin J., and Swann P.G. Cone- and rod-mediated mfERG in early age-related maculopathy. Eye 19 (2005) 431-441
88. Feigl B., Brown B., Lovie-Kitchin J., and Swann P.G. Monitoring retinal function in early age-related maculopathy: visual performance after one year. Eye 19 (2005) 1169-1177
89. Feigl B., Brown B., Lovie-Kitchin J., and Swann P.G. The rod-mediated multifocal electroretinogram in aging and in early age-related maculopathy eyes. Curr. Eye Res. 31 (2006) 635-644
90. Feigl B., Brown B., Lovie-Kitchin J., and Swann P.G. Functional loss in early age-related maculopathy: the ischaemia postreceptoral hypothesis (perspective). Eye 21 (2007) 689-696
91. Feigl B., Greaves A., Aralar A., and Brown B. Long term assessment of localized functional and anatomical outcomes after multiple anti-VEGF treatment in neovascular AMD. Clin. Exp. Ophthalmol. 35 Suppl. 1 (2007) A85
92. Feigl B., Greaves A., and Brown B. Functional outcomes after multiple treatments with ranibizumab in neovascular age-related macular degeneration beyond visual acuity. Clin. Ophthalmol. 2 (2007) 1-9
93. Feigl B., Stewart I., and Brown B. Experimental hypoxia in human eyes: implications for ischaemic disease. Clin. Neurophysiol. 118 (2007) 887-895
94. Feigl B., Stewart I.B., Brown B., and Zele A.J. Local neuroretinal function during acute hypoxia in healthy older people. Invest. Ophthalmol. Vis. Sci. 49 (2008) 807-813
95. Feigl B., and Zele A.J. A method for investigating the temporal dynamics of local neuroretinal responses. J. Neurosci. Methods 167 (2008) 207-213
96. Ferrara N. Vascular endothelial growth factor: molecular and biological aspects. Microbiol. Immunol. 237 (1999) 1-30
97. Ferrara N., Gerber H.P., and LeCouter J. The biology of VEGF and its receptors. Nat. Med. 9 (2003) 669-676
98. Fitch J.C., Rollins S., Matis L., Alford B., Aranki S., Collard C.D., Dewar M., Elefteriades J., Hines R., Kopf G., Kraker P., Li L., O'Hara R., Rinder H., Shaw R., Smith B., Stahl G., and Shernan S.K. Pharmacology and biological efficacy of a recombinant, humanized, single-chain antibody C5 complement inhibitor in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass. Circulation 100 (1999) 2499-2506
99. Friedman E., Krupsky S., Lane A.M., Oak S.S., Friedman E.S., Egan K., and Gragoudas E.S. Ocular blood flow velocity in age-related macular degeneration. Ophthalmology 102 (1995) 640-646
100. Fuchs E. Retinitis circinata. Albrecht von Graefes Arch. Ophthalmol. 39 (1893) 229-279
101. Fung A.E., Lalwani G.A., Rosenfeld P.J., Dubovy S.R., Michels S., Feuer W.J., Puliafito C.A., Davis J.L., Flynn H.W., and Esquiabro M. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (lucventis for neovascular age-related macular degeneration). Am. J. Ophthalmol. 143 (2007) 566-583
102. Gass J.D. Drusen and disciform macular detachment and degeneration. Trans. Am. Ophthalmol. Soc. 70 (1972) 409-436
103. Gass J.D. Drusen and disciform macular detachment and degeneration. Arch. Ophthalmol. 90 (1973) 206-217
104. Gass J.D.M. Pathogenesis of disciform macular detachment of the neuro-epithelium. 3. Senile disciform macular degeneration. Am. J. Ophthalmol. 63 (1967) 617-644
105. Gass J.D.M. Age-related Macular Degeneration. Stereoscopic Atlas of Macular Diseases: Diagnosis and Treatment. fourth ed. (1997), Mosby, St. Louis pp. 70-105
106. Gaudreault J., Fei D., Rusit J., Suboc P., and Shiu V. Preclinical pharmacokinetics of ranibizumab (fhuFabV2) after a single intravitreal administration. Invest. Ophthalmol. Vis. Sci. 46 (2005) 726-733
107. Gaudreault J., Fei D.T., Beyer J.C., Ryan A.M., Rangell L., Shiu V., and Damico L.A. Pharmacokinetics and retinal distribution of ranibizumab, a humanized antibody fragment directed against VEGF-A, following intravitreal administration in rabbits. Retina 27 (2007) 1260-1266
108. Gaudric A., Coscas M.D., and Bird A.C. Choridal ischemia. Am. J. Ophthalmol. 94 (1982) 489-498
109. Gehrs K.M., Anderson D.H., Johnson L.V., and Hageman G.S. Age-related macular degeneration-emerging pathogenetic and therapeutic concepts. Ann. Med. 38 (2006) 450-471
110. Gerth C., Delahunt P.B., Suhail A., Morse L.S., and Werner J.S. Cone-mediated multifocal electroretinogram in age-related macular degeneration. Arch. Ophthalmol. 124 (2006) 345-352
111. Gerth C., Hause D., Delahunt P., Morse L., and Werner J. Assessment of multifocal electroretinogram abnormalities and their relation to morphologic characteristics with large drusen. Arch. Ophthalmol. 121 (2003) 1404-1414
112. Gillies M.C. What we don't know about avastin might hurt us. Arch. Ophthalmol. 123 (2006) 1478
113. Gotoh N., Yamada R., Hiratani H., Renalut V., Kuroiwa S., Monet M., Toyoda S., Chida S., Mandai M., Otani A., Yoshimura N., and Matsuda F. No association between complement factor H gene polymorphism and exudative age-related macular degeneration in Japanese. Hum. Genet. 120 (2006) 139-143
114. Gragoudas E., Adamis A.P., Cunningham E.T., Feinsod M., Guyer D.R., and for the VEGF Inhibition Study in Ocular Neovascularisation Clinical Trial Group. Pegaptanib for neovascular age-related macular degeneration. N. Engl. J. Med. 351 (2004) 2805-2816
115. Granit R. Components of the retinal action potential in mammals and their relations to the discharge in the optic nerve. J. Phys. 77 (1933) 207-238
116. Green W., and Enger C. Age-related macular degeneration histopathological studies. The Lorenz E. Zimmermann Lecture. Invest. Ophthalmol. Vis. Sci. 100 (1993) 1519-1535
117. Grozdanic S.D., Sakaguchi D.S., Kwon Y.H., Kardon R.H., and Sonea I.M. Functional characterization of retina and optic nerve after acute ocular ischemia in rats. Invest. Ophthalmol. Vis. Sci. 44 (2003) 2597-2605
118. Grunwald J.E., Hariprasad S.M., DuPont J., Maguire M.G., Fine S.L., Brucker A.J., Maguire A.M., and Ho A.C. Foveal choroidal blood flow in age-related macular degeneration (AMD). Invest. Ophthalmol. Vis. Sci. 39 (1998) 385-390
119. Grunwald J.E., Metelitsina T.I., DuPont J.C., Ying G.-S., and Maguire M.G. Reduced foveolar choroidal blood flow in eyes with increasing AMD severity. Invest. Ophthalmol. Vis. Sci. 46 (2005) 1033-1038
120. Guymer R., Luthert P., and Bird A.C. Changes in Bruch's membrane and related structures with age. Prog. Retin. Eye Res. 18 (1998) 59-90
121. Haab O. Erkrankungen der Macula Lutea. Centralbl Augenheilkd 9 (1885) 384-391
122. Haddad S., Chen C., Santangelo S.L., and Seddon J.M. The genetics of age-related macular degeneration: a review of progress to date. Surv. Ophthalmol. 51 (2006) 316-363
123. Haegerstrom-Portnoy G., and Brown B. Two-color increment thresholds in early age-related maculopathy. Clin. Vis. Sci. 4 (1989) 165-172
124. Hageman G.S., Anderson D.H., Johnson L.V., Hancox L.S., Taiber A.J., Hardisty L.I., Hageman J.L., Stockman H.A., Borchardt J.D., Gehrs K.M., Smith R.J.H., Silvestri G., Russell S.R., Klaver C.C.W., Barbazetto I., Chang S., Yannuzzi L.A., Barile G.R., Merriam J.C., Smith R.T., Olsh A.K., Bergeron J., Zernant J., Merriam J.E., Gold B., Dean M., and Allikmets R. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. PNAS 102 (2005) 7227-7232
125. Hageman G.S., Hancox L.S., Taiber A.J., Gehrs K.M., Anderson D.H., Johnson L.V., Radeke M.J., Kavanagh D., Richards A., Atkinson J., Meri S., Bergeron J., Zernant J., Merriam J.C., Gold B., Allikmets R., Dean M., and AMD Clinical Study Group. Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications. Ann. Med. 38 (2006)
126. Hageman G.S., Luthert P.J., Victor Chong N.H., Johnson L.V., Anderson D.H., and Mullins R.F. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog. Retin. Eye Res. 20 (2001) 705-732
127. Hageman G.S., and Mullins R.F. Molecular composition of drusen as related to substructural phenotype. Mol. Vis. 5 (1999) 28
128. Haimovici R., Owens S., Fitzke F.W., and Bird A.C. Dark adaptation in age-related macular degeneration: relationship to the fellow eye. Graefe's Arch. Clin. Exp. Ophthalmol. 240 (2002) 90-95
129. Haines J.L., Hauser M.A., Schmidt S., Scott W.K., Olson L.M., Gallins P., Spencer K.L., Kwan S.Y., Noureddine M., Gilbert J., Schnetz-Boutaud N., Agarwal A., Postel E.A., and Pericak-Vance M.A. Complement factor H variant increases the risk of age-related macular degeneration. Science 308 (2005) 419-421
130. Hare W., and Ton H. Effects of APB, PDA, and TTX on ERG responses recorded using both multifocal and conventional methods in monkey. Effects of APB, PDA, and TTX on monkey ERG responses. Doc. Ophthalmol. 105 (2002) 189-222
131. Harris A., Chung H.S., Ciulla T.A., and Kagemann L. Progress in measurement of ocular blood flow and relevance to our understanding of glaucoma and age-related macular degeneration. Prog. Retin. Eye Res. 18 (1999) 669-687
132. Hart W., and Burde R. Three-dimensional topography of the central visual field. Sparing of foveal sensitivity in macular disease. Ophthalmology 90 (1983) 1028-1038
133. Hartridge G. A case of retinitis circinata. Trans. Ophthalmol. Soc. UK 16 (1896) 90-93
134. Hayreh S.S., and Gartner S. In vivo choroidal circulation and its watershed zones. Eye 4 (1990) 273-289
135. Hecht S., Haig C., and Chase A.M. The influence of light adaptation on subsequent dark adaptation of the eye. J. Gen. Physiol. 20 (1937) 831-850
136. Heiduschka P., Fietz H., Hofmeister S., Schultheiss S., Mack A.F., Peters S., Ziemsson F., Niggerman B., Julien S., Barz-Schmidt K.U., Schraermeyer U., and Tuebingen Bevacizumab Study Group. Penetration of bevazizumab through the retina following intravitreal injection in the monkey. Invest. Ophthalmol. Vis. Sci. 48 (2007) 2814-2823
137. Heinemann-Vernaleken B., Palmowski A., Allgayer R., and Ruprecht K. Comparison of different high resolution multifocal electroretinogram recordings in patients with age-related maculopathy. Graefe's Arch. Clin. Exp. Ophthalmol. 239 (2001) 556-561
138. Hogan M.J. Role of the retinal pigment epithelium in macular disease. Trans. Am. Acad. Otolaryngol. Ophthalmol. 76 (1972) 64-80
139. Hogg C.R., and Chakravarthy U. Visual function and dysfunction in early and late age-related maculopathy. Prog. Retin. Eye Res. 25 (2006) 249-276
140. Holekamp N.M., Bouck N.P., and Volpert O.V. Pigment epithelium derived factor is deficient in the vitreous of patients with choroidal neovascularisation due to age-related macular degeneration. Am. J. Ophthalmol. 134 (2002) 220-227
141. Holm E. Retintis exsudative externa. Klin. Monatsbl. Augenheilkd 59 (1917) 319-352
142. Holopigian K., Greenstein V.C., Seiple W., Hood D.C., and Carr R.E. Rod and cone photoreceptor function in patients with cone dystrophy. Invest. Ophthalmol. Vis. Sci. 45 (2004) 275-281
143. Holopigian K., Seiple W., Greenstein V.C., Hood D.C., and Carr R.E. Local cone and rod system function in patients with retinitis pigmentosa. Invest. Ophthalmol. Vis. Sci. 42 (2001) 779-788
144. Holz F.G., Sheraidah G.S., Pauleikhoff D., and Bird A.C. Analysis of lipid deposits extracted from human macular and peripheral Bruch's membrane. Arch. Ophthalmol. 112 (1994) 402-406
145. Hood D.C. Assessing retinal function with the multifocal technique. Prog. Retin. Eye Res. 19 (2000) 607-646
146. Hood D.C., Bach M., Brigell M., Keating D., Kondo M., Lyons J.S., and Palmowski-Wolfe A.M. Standard for clinical multifocal electroretinography (2007). http://www.iscev.org/standards/index.html
147. Hood D.C., Frishman L.J., Saszik S., and Viswanathan S. Retinal origins of the primate multifocal ERG. Implication for the human response. Invest. Ophthalmol. Vis. Sci. 43 (2002) 1673-1685
148. Hood D.C., Frishman L.J., Viswanathan S., Robson J.G., and Ahmed J. Evidence for a ganglion cell contribution to the primate electroretinogram (ERG): effects of TTX on the multifocal ERG in macaque. Vis. Neurosci. 16 (1999) 411-416
149. Hood D.C., Greenstein V., Frishman L.J., Holopigian K., Viswanathan S., Seiple W., Ahmed J., and Robson J.G. Identifying inner retinal contributions to the human multifocal electroretinogram. Vision Res. 39 (1999) 2285-2291
150. Hood D.C., Seiple W., Holopigian K., and Greenstein V.C. A comparison of the components of the multifocal and full-field ERGs. Vis. Neurosci. 14 (1997) 533-544
151. Hood D.C., Wladis E.J., Shady S., Holopigian K., Li J., and Seiple W. Multifocal rod electroretinograms. Invest. Ophthalmol. Vis. Sci. 39 (1998) 1152-1161
152. Horiguchi M., Suzuki S., Kondo M., Tanikawa A., and Miyake Y. Effect of glutamate analogues and inhibitory neurotransmitters on the electroretinograms elicited by random sequence stimuli in rabbits. Invest. Ophthalmol. Vis. Sci. 39 (1998) 2171-2176
153. Howell V.H., McNamara D.J., Tosca M.A., Smith B.T., and Gaines J.A. Plasma lipid and lipoprotein responses to dietary fat and cholesterol: a metaanalysis. Am. J. Clin. Nutr. 65 (1997) 1747-1764
154. Huang S., Wu D., Jiang F., Ma J., Wu L., Liang J., and Luo G. The multifocal electroretinogram in age-related maculopathies. Doc. Ophthalmol. 101 (2000) 115-124
155. Huang S.J., Costa D.L., Gross N.E., and Yannuzzi L.A. Peripheral drusen in membranoproliferative glomerulonephritis type II. Retina 23 (2003) 429-431
156. Hutchinson J., and Tay W. Symmetrical central choroido-retinal disease occurring in senile persons. R. London Ophthalmic Hosp. Rep. J. Ophthalmic Med. Surg. 8 (1874) 231-244
157. Hwang J.C., Chan J.W.K., Chang S., and Smith R.T. Predictive value of fundus autofluorescence for development of geographic atrophy in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 47 (2006) 2655-2661
158. Hyman L. Epidemiology of AMD. In: Hampton R.G., and Nelson P.T. (Eds). Age Related Macular Degeneration: Principles and Practice (1992), Raven Press, New York 1-35
159. Hyman L., Schachat A.P., He Q., and Leske M. Hypertension, cardiovascular disease, and age-related macular degeneration: Age-Related Macular Degeneration Risk Factors Study Group. Arch. Ophthalmol. 117 (2000) 351-358
160. Ikeda H., Hankins M.W., Asai T., and Dawes E.A. Electrophysiological properties of neurons following mild and acute retinal ischemia. Exp. Eye Res. 55 (1992) 435-442
161. de Jong P.T. Age-related macular degeneration. N. Engl. J. Med. 355 (2006) 1474-1485
162. Jackson C.A., McGwin G., Phillips J.M., Klein R., and Owsley C. Impact of aging and age-related maculopathy on activation of the a-wave of the rod-mediated electroretinogram. Invest. Ophthalmol. Vis. Sci. 45 (2004) 3271-3278
163. Jager R.D., Mieler W.F., and Miller J.W. Age-related macular degeneration. N. Engl. J. Med. 24 (2008) 2607-2617
164. Jakobsdottir J., Conley Y.P., Weeks D.E., Mah T.S., Ferrel R.E., and Gorin M.B. Susceptibility genes for age-related maculopathy on chromosome 10q26. Am. J. Hum. Genet. 77 (2005) 389-407
165. Johnson L.V., and Campos E. Complement activation and inflammatory process in drusen formation and age-related macular degeneration. Exp. Eye Res. 73 (2001) 887-896
166. Jones R., King-Smith P., Loffing D., and Gaynier F. Stray light contributions to the focal electroretinogram (ERG). Clin. Vis. Sci. 1 (1986) 153-160
167. Junius P., and Kuhnt H. Die scheibenfoermige Entartung der Netzhautmitte (Degeneratio maculae lateae disciformis) (1926), Karger, Berlin
168. Kaiser P.K., Blodi B.A., Shapiro H., Acharya N.R., and MARINA Study Group. Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration. Ophthalmology 114 (2007) 1868-1875
169. Kaiserman I., and Frucht-Pery J. Anterior ischemic optic neuropathy after a trans-Atlantic airplane journey. Am. J. Ophthalmol. 133 (2002) 581-583
170. Kalayoglu M.V., Galvan C., Mahdi O.S., Byrne G.I., and Mansour S. Serological association between Chlamydia pneumoniae infection and age-related macular degeneration. Arch. Ophthalmol. 121 (2003) 478-482
171. Kang Derwent J.J., and Linsenmeier R.A. Effects of hypoxemia on the a- and b-waves of the electroretinogram in the cat retina. Invest. Ophthalmol. Vis. Sci. 41 (2000) 3634-3642
172. Karakucuk S., Oner A.O., Gotkas S., Siki E., and Kose O. Color vision changes in young subjects acutely exposed to 3000 m altitude. Aviat. Space Environ. Med. 75 (2004) 364-366
173. Kergoat H., Herard M.-E., and Lemay M. RCG sensitivity to mild systemic hypoxemia. Invest. Ophthalmol. Vis. Sci. 47 (2006) 5423-5427
174. Keys A. Coronary heart disease in seven countries. Circulation 41 (1970) 1162-1175
175. Kiel J.W., and van Heuven W.A. Ocular perfusion pressure and choroidal blood flow in the rabbit. Invest. Ophthalmol. Vis. Sci. 36 (1995) 579-585
176. Killingsworth M.C. Angiogenesis in early choroidal neovascularisation secondary to age-related macular degeneration. Graefe's Arch. Clin. Exp. Ophthalmol. 233 (1995) 1995
177. Kiryu J., Asrani S., Shahidi M., Mori M., and Zeimer R. Local response of the primate retinal microcirculation to increased metabolic demand induced by flicker. Invest. Ophthalmol. Vis. Sci. 36 (1995) 1240-1246
178. Klaver C.C., Hoyng C.B., and de Jong P.T. Pigmentary irregularities and optic disc edema after heart transplantation. Arch. Ophthalmol. 113 (1995) 1281-1285
179. Klein R. Overview of progress in epidemiology of age-related macular degeneration. Ophthalmic Epidemiol. 14 (2007) 184-187
180. Klein R., Davis M.D., Magli Y.L., Segal P., Klein B.E.K., and Hubbard L.
181. Klein R., Klein B.E., Jensen S.C., and Meuer S.M. The five-year incidence and progression of age-related maculopathy: The Beaver Dam Eye Study. Ophthalmology 104 (1997) 7-21
182. Klein R., Klein B.E., and Linton K.L. Prevalence of age-related maculopathy. Ophthalmology 99 (1992) 933-943
183. Klein R., Klein B.E., Linton K.L., and DeMets D.L. The Beaver Dam Eye Study: the relation of age-related maculopathy to smoking. Am. J. Epidemiol. 137 (1993) 190-200
184. Klein R., Klein B.E., and Moss S.E. Relation of smoking to the incidence of age-related maculopathy. The Beaver Dam Eye Study. Am. J. Epidemiol. 147 (1998) 103-110
185. Klein R., Klein B.E.K., and Jensen S. The relation of cardiovascular disease and its risk factors to the 5-year incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 104 (1997) 1804-1812
186. Klein R., Klein B.E.K., Marino E.K., Kuller L.H., Furberg C., Burke G.L., and Hubbard L.D. Early age-related maculopathy in the cardiovascular health study. Ophthalmology 110 (2003) 25-33
187. Klein R., Klein B.E.K., Tomany S.C., and Cruickshanks K.J. The association of cardiovascular disease with long term incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 110 (2003) 636-643
188. Klein R.J., Zeiss C., Chew E.Y., Tsai J.-Y., Sackler R.S., Haynes C., Henning A.K., SanGiovanni J.P., Mane S.M., Mayne S.T., Bracken M.B., Ferris F.L., Ott J., Barnstable C., and Hoh J. Complement factor H polymorphism in age-related macular degeneration. Science 308 (2005) 385-389
189. Klemp K., Lund-Andersen H., Sander B., and Larsen B. The effect of acute hypoxia and hyperoxia on the slow flash multifocal electroretinogram in healthy subjects. Invest. Ophthalmol. Vis. Sci. 48 (2007) 3405-3412
190. Kliffen M., Sharma H.S., Mooy C.M., Kerkvliet S., and de Jong P.T. Increased expression of angiogenic growth factors in age-related maculopathy. Br. J. Ophthalmol. 81 (1997) 154-162
191. Kopsa H., Bettelheim H., Grabner G., Schmidt P., Zazgornik J., Balcke P., and Pils P. Long-term observation of ocular findings after renal transplantation. Proc. Eur. Dial. Transplant Assoc. 15 (1978) 372-377
192. Kornzweig A.B. Changes in the choriocapillaris associated with senile macular degeneration. Ann. Ophthalmol. 9 (1977) 753-764
193. Kowanetz M., and Ferrara N. Vascular endothelial growth factor signaling pathways: therapeutic perspective. Clin. Cancer Res. 12 (2006) 5018-5022
194. Kremers J. The assessment of L- and M-cone specific electroretinographical signals in the normal and abnormal human retina. Prog. Retin. Eye Res. 22 (2003) 579-605
195. Kvanta A., Algvere P.V., Berglin L., and Seregard S. Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor. Invest. Ophthalmol. Vis. Sci. 37 (1996) 1929-1934
196. Lamb T.D., and Pugh E.N. A quantitative account of the activation steps involved in phototransduction in amphibian photoreceptors. J. Physiol. 449 (1992) 719-758
197. Lamb T.D., and Pugh E.N. Dark adaptation and the retinoid cycle of vision. Prog. Retin. Eye Res. 23 (2004) 307-380
198. Lee P., Wang C.D., and Adamis A.P. Ocular neovascularisation: an epidemiologic overview. Surv. Ophthalmol. 43 (1998) 245-269
199. Leibowitz H.M., Krueger D.E., Maunder L.R., Milton R.C., Kini M.M., Kahn H.A., Nickerson R.J., Pool J., Colton T.L., Ganley J.P., Loewenstein J.I., and Dawber T.R. The Framingham Eye Study monograph: an ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975. Surv. Ophthalmol. 25 (1980) 333-610
200. Li J., Tso M., and Lam T. Reduced amplitude and delayed latency in foveal response of multifocal electroretinogram in early age related macular degeneration. Br. J. Ophthalmol. 85 (2001) 287-290
201. Linsenmeier R.A. Electrophysiological consequences of retinal hypoxia. Graefe's Arch. Clin. Exp. Ophthalmol. 228 (1990) 143-150
202. Linsenmeier R.A., and Braun R.D. Oxygen distribution and consumption in the cat retina during normoxia and hypoxia. J. Gen. Physiol. 99 (1992) 177-197
203. Linsenmeier R.A., Mines A.H., and Sternberg R.H. Effects of hypoxia and hypercapnia on the light peak and electroretinogram of the cat. Invest. Ophthalmol. Vis. Sci. 24 (1983) 37-46
204. Linsenmeier R.A., Smith V.C., and Pokorny J. The light rise of the electrooculogram during hypoxia. Clin. Vis. Sci. 2 (1987) 111-116
205. Lipski A., Bornfeld N., and Jurklies B. Multifocal electroretinography in patients with exudative and intravitreal treatment with pegaptanib sodium. Retina 27 (2007) 864-872
206. Loeffler K.U., and Lee W.R. Basal linear deposits in the human macula. Graefe's Arch. Clin. Exp. Ophthalmol. 224 (1986) 493-501
207. van Leeuwen R., Ikram M.K., Vingerling J.R., Witteman J.C.M., Hofman A., and de Jong P. Blood pressure, atherosclerosis and the incidence of age-related maculopathy: the Rotterdam Study. Invest. Ophthalmol. Vis. Sci. 44 (2003) 3771-3777
208. van Leeuwen R., Klaver C.W., Vingerling J.R., Hofman A., and de Jong P.T. The risk and natural course of age-related maculopathy. Follow-up at 6 1/2 years in the Rotterdam Study. Arch. Ophthalmol. 121 (2003) 519-526
209. Maller J., George S., Purcell S., Fagerness J., Altshuler Dd M.J., and Seddon J.M. Common variation in three genes, including a noncoding variant of CFH, strongly influences risk of age-related macular degeneration. Nat. Genet. 38 (2007) 1055-1059
210. Manzano R.P.A., Peyman G.A., Khan P., and Kivilcim M. Testing intravitreal toxicity of bevacizumab (Avastin). Retina 26 (2006) 257-261
211. Massay S.C. Cell types using glutamate as a neurotransmitter in the vertebrate retina. In: Osborne N.N., and Chader G.J. (Eds). Progress in Retinal Research (1990), Pergamon Press, Oxford, UK 339-425 (Chapter 9)
212. Maturi R.K., Bleau L.A., and Wilson D.L. Electrophysiologic findings after intravitreal bevacizumab (Avastin) treatment. Retina 26 (2006) 270-274
213. McFarland R.A., and Evans A. Dark adaptation and reduced oxygen tension. Am. J. Physiol. 127 (1939) 37-50
214. Melrose M.A., Magargal L.E., Goldberg R.E., and Annesley W.H.J. Subretinal neovascular membranes associated with choroidal nonperfusion and retinal ischemia. Ann. Ophthalmol. 19 (1984) 396-399
215. Metelitsina T.I., Grunwald J.E., DuPont J.C., Gui-Shuang Y., Brucker A.J., and Dunaief J.L. Foveolar choroidal circulation and choroidal neovascularisation in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 49 (2008) 358-363
216. Michel J. Ueber die Geschwuelste des Uvealtractus. Albrecht von Graefes Arch. Ophthalmol. 24 (1878)
217. Midena E., Degli A., Blarzino M., Valenti M., and Segato T. Macular function impairment in eyes with early age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 38 (1997) 469-477
218. Mitchell P., Wang J.J., Smith W., and Leeder S.R. Smoking and the 5-years incidence of age-related maculopathy: The Blue Mountain Eye Study. Arch. Ophthalmol. 120 (2002) 1357-1363
219. Mitka M. Study aims to clarify efficacy, safety of eye drug treatments. JAMA 297 (2007) 1538-1539
220. Miyake Y., Awaya S., Takahashi H., Tomita N., and Hirano K. Hyperbaric oxygen and acetazolamid improve visual acuity in patients with cystoid macular edema by different mechanisms. Arch. Ophthalmol. 111 (1993) 1605-1606
221. Miyake Y., Yanagida K., Kondo M., Yagasaki K., and Ohta I. Subjective scotometry and recording of local electroretinogram and visual evoked response system with television monitor of the fovea. Jpn. J. Ophthalmol. 25 (1981) 438-448
222. Mohand-Said S., Hicks D., Simonutti M., Tran-Minh D., Deudon-Combe A., Dreyfus H., Silverman M.S., Oqilvie J.M., Tenkova T., and Sahel J. Photoreceptor transplants increase host cone survival in the retinal degeneration (rd) mouse. Ophthalmic Res. 29 (1997) 290-297
223. Mohand-Said S., Deudon-Combe A., Hicks D., Simonutti M., Forster V., Fintz A.-C., Leveillard T., Dreyfus H., and Sahel J.A. Normal retina releases a diffusable factor stimulating cone survival in the retinal degeneration mouse. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 8357-8362
224. Mollon J.D. Post-receptoral processes in colour vision. Nature 283 (1980) 623-624
225. Montalvo V., Chan C.C., Gery I., Campos M.M., Wawrousek E.F., Bush R.A., and Lambris J.D. Complement deposits on ocular tissues adjacent to sites of inflammation. Curr. Eye Res. 32 (2007) 917-922
226. Moschos M.M., Brouzas D., Apostolopoulos M., Koutsandrea C., Loukianou E., and Moschos M. Intravitreal use of bevacizumab (Avastin) for choroidal neovascularization due to ARMD: a preliminary multifocal-ERG and OCT study: multifocal-ERG after use of bevacizumab in ARMD. Doc. Ophthalmol. 114 (2007) 37-44
227. Moser C., Lang S.A., and Stoeltzing O. The direct effects of anti-vascular endothelial growth factor therapy on tumor cells. Clin. Colorectal Cancer 6 (2007) 564-571
228. Moshfeghi A.A., and Puliafito C.A. Pegaptanib sodium for the treatment of neovascular age-related macular degeneration. Expert Opin. Investig. Drugs 14 (2005) 671-682
229. Moshfeghi A.A., Rosenfeld P.J., Puliafito C.A., Michels S., Marcus E.N., Lenchus J.D., and Venkatraman A.S. Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration: twenty-four-week results of an uncontrolled open-label clinical study. Ophthalmology 113 (2006) 2002 e1-12
230. Mullins R.F., Aptsiauri N., and Hageman G.S. Structure and composition of drusen associated with glomerulonephritis: implication for the role of complement activation in drusen. Eye 15 (2001) 390-395
231. Naarendorp F., and Sieving P. The scotopic threshold response of the cat ERG is suppressed selectively by GABA and glycine. Vision Res. 31 (1991) 1-15
232. Napper G.A., and Kalloniatis M. Neurochemical changes following postmortem ischemia in the rat retina. Vis. Neurosci. 16 (1999) 1169-1180
233. Nguyen Q.D., Shah S.M., Van Anden E., Sung J.U., Vitale S., and Campochiaro P.A. Supplemental oxygen improves diabetic macular edema: a pilot study. Invest. Ophthalmol. Vis. Sci. 45 (2004) 617-624
234. 2 on the ERG in the cat. Invest. Ophthalmol. Vis. Sci. 23 (1982) 678-683
235. Nishijima K., Ng Y.-S., Zhong L., Bradley J., Schubert W., Jo N., Akita J., Samuelson S.J., Robinson G.S., Adamis A.P., and Shima D.T. Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during adaptive response to ischemic injury. Am. J. Pathol. 171 (2007) 53-67
236. Obermann A.E., and Chatterjee S.N. Ocular complications in renal transplant recipients. West J. Med. 123 (1975) 184-187
237. Oeller, J., 1873. Atlas der Ophthalmoskopie. In: Bergman, J.F. (Ed.), Wiesbaden.
238. Ohno-Matsui K., Morita I., Tombran-Tink J., Mrazek D., Onodera M., Uetama T., Hayano M., Murota S.-I., and Mochizuki M. Novel mechanism for age-related macular degeneration: an equilibrium shift between the angiogenesis factors VEGF and PEDF. J. Cell. Physiol. 189 (2001) 323-333
239. Oka C., Tsujimoto R., Kajikawa M., Koshiba-Takeuchi K., Ina J., Yano M., Tsuchiya A., Ueta Y., Soma A., and Kanda H. HtrA1 serine protease inhibits signalling mediated by TGFb family proteins. Development 131 (2004) 1041-1053
240. Osborne N.N., Casson E.J., Wood J.P.M., Chidlow G., Graham M., and Melena J. Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog. Retin. Eye Res. 23 (2004) 91-147
241. Osborne N.N., and Larsen A.K. Antigens associated with specific retinal cells are affected by ischaemia caused by raised intraocular pressure: effect of glutamate antagonists. Neurochem. Int. 29 (1996) 263-270
242. Osborne N.N., Schwarz M., and Pergande G. Protection of rabbit retina from ischemic injury by flupirtine. Invest. Ophthalmol. Vis. Sci. 37 (1996) 274-280
243. Owsley C., Jackson G., Cideciyan A., Huang Y., Fine S., Ho A., Marguire M., Lolley V., and Jacobson S. Psychophysical evidence for rod vulnerability in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 41 (2000) 267-273
244. Owsley C., Jackson G.R., White M., and Edwards D. Delays in rod-mediated dark-adaptation in early age-related maculopathy. Ophthalmology 108 (2001) 1196-1202
245. Pagenstecher, H., Genth, C.P., 1875. Atlas der pathologischen Anatomie des Augapfels. In: C.W. Kreidel (Ed.), Wiesbaden.
246. Palmowski A., Allgayer R., Heinemann-Vernaleken B., and Ruprecht K. First and second order changes in the multifocal electroretinogram of patients with different forms of age related macular degeneration. Vision Science and its Applications. OSA Tech Dig Ser (2001), Optical Society of America, Washington, DC 32-35
247. Palmowski A., Sutter E., Bearse M., and Fung W. Multifocal electroretinogram (MF-ERG) in diagnosis of macular changes. Example: senile macular degeneration [in German]. Ophthalmologie 96 (1999) 166-173
248. Palmowski A.M., Allgayer R., Heinemann-Vernaleken B., and Ruprecht K.W. Influence of photodynamic therapy in choroidal neovascularization on focal retinal function assessed with the multifocal electroretinogram and perimetry. Ophthalmology 109 (2002) 1788-1792
249. Patel P.J., Bunce C., Tufail A., and Abc Trial Investigators OB. A randomised, double-masked phase III/IV study of the efficacy and safety of Avastin(R) (Bevacizumab) intravitreal injections compared to standard therapy in subjects with choroidal neovascularisation secondary to age-related macular degeneration: clinical trial design. Trials 9 (2008) 56
250. Pauleikhoff D., Chen J.C., Chisholm I.H., and Bird A.C. Choroidal perfusion abnormality with age-related Bruch's membrane change. Am. J. Ophthalmol. 109 (1990) 211-217
251. Pauleikhoff D., Harper C.A., Marshall J., and Bird A.C. Ageing changes in Bruch's membrane. A histochemical and morphological study. Ophthalmology 97 (1990) 171-178
252. Pauleikhoff D., Spital G., Radermacher M., Brumm G.A., Lommatzsch A., and Bird A.C. A fluorescein and indocyanine green angiographic study of choriocapillaris in age-related macular disease. Arch. Ophthalmol. 117 (1999) 1353-1358
253. Pauleikhoff D., Zuels S., and Sheraidah G.S. Correlation between biochemical composition and fluorescein binding of deposits in Bruch's membrane. Ophthalmology 99 (1992) 1548-1553
254. Pavlidis M., Stupp T., Georgalas I., Georgiaduo E., Moschos M., and Thanos S. Multifocal electroretinography changes in the macula at high altitude: a report of three cases. Ophthalmologica 219 (2005) 404-412
255. Penfold P.L., Killingsworth M.C., and Sarks S.H. Senile macular degeneration: the involvement of immunocompetent cells. Graefe's Arch. Clin. Exp. Ophthalmol. 223 (1985) 69-76
256. Penfold P.L., Madigan M.C., Gillies M.C., and Provis J.M. Immunological and aetiological aspects of macular degeneration. Prog. Retin. Eye Res. 20 (2001) 385-414
257. Penfold P.L., Provis J.M., and Billson F.A. Age-related macular degeneration: ultrastructural studies of the relationship of leucocytes to angiogenesis. Graefe's Arch. Clin. Exp. Ophthalmol. 225 (1987) 70-76
258. Phipps J.A., Dang T.M., Vingrys A.J., and Guymer R.H. Flicker perimetry losses in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 45 (2004) 3355-3360
259. Phipps J.A., Guymer R.H., and Vingrys A.J. Loss of cone function in age-related maculopathy. Invest. Ophthalmol. Vis. Sci. 44 (2003) 2277-2283
260. Pokorny J., Smithson H., and Quinlan J. Photostimulator allowing independent control of rods and the three cone types. Vis. Neurosci. 21 (2004) 263-267
261. Ramrattan R.S., van der Schaft T.L., Mooy C.M., de Bruijin W.C., Mulder P.H.G., and de Jong P.T.V.M. Morphometric analysis of Bruch's membrane, the choriocapillaris, and the choroid in aging. Invest. Ophthalmol. Vis. Sci. 35 (1994) 2857-2864
262. Rangaswamy N.V., Hood D.C., and Frishman L.J. Regional variations in local contributions to the primate photopic flash ERG: revealed using the slow-sequence mfERG. Invest. Ophthalmol. Vis. Sci. 44 (2003) 3233-3247
263. Regillo C.D., Brown D.M., Abraham P., Yue H., Ianchulev T., Schneider S., Shams N., and The PIER Study Group. Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER study year 1. Am. J. Ophthalmol. 145 (2008) 239-248
264. Remky A., Lichtenberg K., Elsner A.E., and Arend O. Short wavelength automated perimetry in age-related maculopathy. Br. J. Ophthalmol. 85 (2001) 1432-1436
265. Remulla J.F.C., Gaudio A.R., Miller S., and Sandberg M.A. Foveal electroretinograms and choroidal perfusion characteristics in fellow eyes of patients with unilateral neovascular age-related macular degeneration. Br. J. Ophthalmol. 79 (1995) 558-561
266. Rich B., Rosenfeld P.J., Puliafito C.A., Dubovy S.R., Davis J.L., Flynn H.W.J., Gonzalez S., Feuer W.J., Lin R.C., Lalwani G.A., Nguyen J.K., and Kumar G. Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Retina 26 (2006) 495-511
267. Riedemann N.C., and Ward P.A. Complement in ischemia reperfusion injury. Am. J. Pathol. 162 (2003) 363-367
268. Riva C.E., Logean E., and Falsini B. Visually evoked hemodynamical response and assessment of neurovascular coupling in the optic nerve and retina. Prog. Retin. Eye Res. 24 (2005) 183-215
269. Riva C.E., Titze P., Hero M., and Petrig B.L. Effect of acute decreases of perfusion pressure on choroidal blood flow in humans. Invest. Ophthalmol. Vis. Sci. 38 (1997) 1752-1760
270. Robbins S., and Cotran R.S. Pathologic basis of disease. In: Kumar V., Abbas A.K., and Fausto N. (Eds). Robbins and Cotran pathologic basis of disease. seventh ed. (2004), Saunders, Philadelphia
271. Robman L., Mahdi O.S., Wang J.J., Burlutsky G., Mitchell P., Byrne G., Guymer R., and Taylor H. Exposure to Chlamydia pneumoniae infection and age-related macular degeneration: the Blue Mountains Eye Study. Invest. Ophthalmol. Vis. Sci. 48 (2007) 4007-4011
272. Rodrigues E.B., Shiroma H., Meyer C.H., Maia M., and Farah M.E. Metrorrhagia after intravitreal injection of bevacizumab. Acta Ophthalmol Scand. (2007) 10.1111/j.1600-0420.2007.00968.x
273. Romano C., Price M., Baui H.Y., and Olney J.W. Neuroprotectants in Honghua: glucose attenuates retina ischemic damage. Invest. Ophthalmol. Vis. Sci. 34 (1993) 72-80
274. Rosenfeld P.J., Brown D.M., Heier J.S., Boyer D.S., Kaiser P.K., Chung C.Y., Kim R.Y., and MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N. Engl. J. Med. 355 (2006) 1419-1431
275. Rosenfeld P.J., Rich R.M., and Lalwani G.A. Ranibizumab: phase III clinical trial results. Ophthalmol. Clin. North Am. 19 (2006) 361-372
276. Ross R., Barofsky J., Cohen G., Barber W., Palao S., and Gitter K. Presumed macular choroidal watershed vascular filling, choroidal neovascularisation, and systemic vascular disease in patients with age-related macular degeneration. Am. J. Ophthalmol. 125 (1998) 71-80
277. Ross R., Verma V., Rosenberg K., and Chan C.-C. Genetic markers and biomarkers for age-related macular degeneration. Exp. Rev. Ophthalmol. 2 (2007) 443-457
278. Roy C.S., and Sherrington C.S. On the regulation of the blood supply of the brain. J. Physiol. 11 (1890) 85-158 17
279. Rueckmann A.V., Fitzke F.W., and Bird A.C. Fundus autofluorescence in age-related macular degeneration imaged with a laser scanning ophthalmoscope. Invest. Ophthalmol. Vis. Sci. 38 (1997) 478-486
280. Ryan S.J. Subretinal neovascularisation. Natural history of an experimental model. Arch. Ophthalmol. 100 (1982) 1804-1809
281. Ryan S.J., Hinton D.R., and Murata T. Choroidal neovascularisation. In: Ryan S.J., and Schachat A.P. (Eds). Retina. fourth ed. (2006), Mosby, Philadelphia 991-1009
282. Sandberg M.A., and Ariel M. A hand-held two channel stimulator ophthalmoscope. Arch. Ophthalmol. 95 (1977) 1881-1882
283. Sandberg M.A., Miller S., and Gaudio A.R. Foveal cone ERGs in fellow eyes of patients with unilateral neovascular age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 34 (1993) 3477-3480
284. SanGiovanni J.P., Chew E.Y., Agrón E., Clemons T.E., Ferris F.L., Gensler G., Lindblad A.S., Milton R.C., Seddon J.M., Klein R., Sperduto R.D., and Age-Related Eye Disease Study Research Group. The relationship of dietary omega-3 long-chain polyunsaturated fatty acid intake with incident age-related macular degeneration: AREDS report no. 23. Arch. Ophthalmol. 126 (2008) 1274-1279
285. Sarks J.P., Sarks S.H., and Killingsworth M.C. Morphology of early choroidal neovascularisation in age-related macular degeneration: correlation with activity. Eye 11 (1997) 515-522
286. Sarks J.P., Sarks S.H., and Killingworth M.C. Evolution of geographic atrophy of the retinal pigment epithelium. Eye 2 (1988) 552-577
287. Sarks J.P., Sarks S.H., and Killingworth M.C. Evolution of soft drusen in age-related macular degeneration. Eye 8 (1994) 269-283
288. Sarks S.H. New vessel formation beneath the retinal pigment epithelium in senile eyes. Br. J. Ophthalmol. 57 (1973) 951-965
289. Sarks S.H. Ageing and degeneration in the macular region: a clinico-pathological study. Br. J. Ophthalmol. 60 (1976) 324-341
290. Sarks S.H. Council Lecture. Drusen and their relationship to senile macular degeneration. Aust. J. Ophthalmol. 8 (1980) 117-130
291. Sarks S.H., Cherepanaoff S., Killingsworth M., and Sarks J.P. Relationship of basal laminar deposits and membranous debris to the clinical presentation of early age-related maculopathy. Invest. Ophthalmol. 48 (2007) 968-977
292. Sarks S.H., Killingsworth M.C., and Sarks J.P. Early drusen formation in the normal and aging eye and their relation to age related maculopathy: a clinicopathological study. Br. J. Ophthalmol. 83 (1999) 358-368
293. Sarks S.H., Van Driel D., Maxwell L., and Killingsworth M. Softening of drusen and subretinal neovascularisation. Trans. Ophthalmol. Soc. UK 100 (1980) 414-422
294. Schäfer H., Mathey D., Hyugo F., and Bhakdi S. Deposition of terminal C5b-9 complement complex in infarcted areas of human myocardium. J. Immunol. 137 (1986) 1945-1949
295. Schlingemann R. Role of growth factors and the wound healing response in age-related macular degeneration. Graefe's Arch. Clin. Exp. Ophthalmol. 242 (2004) 91-101
296. Schmidt-Erfurth U.M., and Pruente C. Management of neovascular age-related macular degeneration. Prog. Retin. Eye Res. 26 (2007) 437-451
297. Seddon J.M., and Chen C.A. The epidemiology of age-related macular degeneration. Int. Ophthalmol. Clin. 44 (2004) 17-39
298. Seddon J.M., Sharma S., and Adelman R.A. Evaluation of the clinical age-related maculopathy staging system. Ophthalmology 113 (2006) 260-266
299. Seddon J.M., Willett W.C., Speizer F.E., and Hackinson S.E. A prospective study of cigarette smoking and age-related macular disease in women. JAMA 276 (1996) 1141-1146
300. Seiple W., Siegel I., Carr R., and Mayron C. Objective assessment of modulation transfer functions using the focal ERG. Am. J. Ophthalmol. 63 (1986) 1-6
301. Shahar J., Avery R.L., Heilweil G., Barak A., Zemel E., Lewis G.P., Johnson P.T., Fisher S.K., Perlman I., and Loewenstein A. Electrophysiologic and retinal penetration studies following intravitreal injection of bevacizumab (Avastin). Retina 26 (2006) 262-269
302. Shapiro A.G., Pokorny J., and Smith V.C. Cone-rod receptor spaces with illustrations that use CRT phosphor and light-emitting-diode spectra. J. Opt. Soc. Am. A: Opt. Image Sci. Vis. 13 (1996) 2319-2328
303. Shen J.K., Dong A., Hackett S.F., Bell W.R., Green W.R., and Campochiaro P.A. Oxidative damage in age-related macular degeneration. Histol. Histopathol. 22 (2007) 1301-1308
304. Shima D.T., Adamis A.P., Ferrara N., Yeo T.K., Yeo K.T., Allende R., Folkman J., and D'Amore P.A. Hypoxic induction of endothelial cell growth factors in retinal cells: identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen. Mol. Med. 1 (1995) 182-193
305. Silcock A.Q. Choroidal gumma. Trans. Am Ophthalmol. Soc. UK 19 (1898-1899) 69-71
306. Smiddy W., and Fine S. Prognosis of patients with bilateral macular drusen. Ophthalmology 91 (1984) 271-277
307. Smith D., Assink J., Klein R., Mitchell P., Klaver C.C., Klein B.E., Hofman A., Jensen S., Wang J.J., and de Jong P.T. Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology 108 (2001) 697-701
308. Smith V.C., Ernest T.J., and Pokorny J. Effect of hypoxia on FM 100-hue test performance. Mod. Probl. Ophthalmol. 17 (1976) 248-256
309. Smith V.C., Pokorny J., and Diddie K.R. Color matching and Stiles-Crawford effect in observers with early age-related macular degeneration. J. Opt. Soc. Am. A 5 (1988) 2113-2121
310. Smith W., Mitchell P., and Leeder S.R. Smoking and age-related maculopathy: the Blue Mountain Eye Study. Arch. Ophthalmol. 114 (1996) 1518-1523
311. Snow K.K., and Seddon J.M. Do age-related macular degeneration and cardiovascular diseases share common antecedents?. Ophthalmol. Epidemiol. 6 (1999) 125-143
312. Spaide R., Laud K., Fine H.F., Klancnik J.M.J., Meyerle C.B., Yannuzzi L.A., Sorenson J., Slakter J.S., Fisher Y.L., and Cooney M.J. Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration. Retina 26 (2006) 383-390
313. Sparrow J.R., Nakanishi K., and Parish C.A. The lipofuscin fluorophore AE2 mediates blue light induced damage to the retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 41 (2001) 1981-1989
314. Stahl G.L., Xu Y., Hao L., Miller M., Buras J.A., Fung M., and Zhao H. Role for the alternative complement pathway in ischemia/reperfusion injury. Am. J. Pathol. 162 (2003) 449-455
315. Steinmetz R., Haimovici R., Jubb C., Fitzke F., and Bird A. Symptomatic abnormalities of dark adaptation in patients with age-related Bruch's membrane change. Br. J. Ophthalmol. 77 (1993) 549-554
316. Stiles W.S. Color vision: the approach through increment threshold sensitivity. Proc. Natl. Acad. Sci. U.S.A. 45 (1959) 100-114
317. Suner I.J., Espinosa-Heidmann D.G., Marin-Castano M.E., Hernandez E.P., Pereira-Simon S., and Cousins S.W. Nicotine increases size and severity of experimental choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 45 (2004) 311-317
318. Sutter E.E., and Tran D. The field topography of ERG components in man. I. The photopic luminance response. Vision Res. 32 (1992) 433-446
319. Swann P., and Lovie-Kitchin J. Age-related maculopathy. II: the nature of the central visual field loss. Ophthalmic Physiol. Opt. 11 (1991) 59-70
320. Swaroop A., Branham K.E., Chen W., and Abecasis G. Genetic susceptibility to age-related macular degeneration: a paradigm for dissecting complex disease traits. Hum. Mol. Genet. 2 (2007) R174-R182
321. Tan J.S., Mitchell P., Kifley A., Flood V., Smith W., and Wang J.J. Smoking and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Arch. Ophthalmol. 125 (2007) 1089-1095
322. Tan J.S., Mitchell P., Smith W., and Wang J.J. Cardiovascular risk factors and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Ophthalmology 114 (2007) 1143-1150
323. Thakkinstian A., Han P., McEvoy M., Smith W., Hoh J., Magnusson K., Zhang K., and Attia J. Systematic review and meta-analysis of the association between complement factor H Y402H polymorphisms and age-related macular degeneration. Hum. Mol. Genet. 15 (2006) 2784-2790
324. The International (ARM) Epidemiological Study Group. An international classification and grading system for age-related macular degeneration. Surv. Ophthalmol. 39 (1995) 367-374
325. Thurman J.M., Ljubanovic D., Edelstein C.L., Gilkeson G.S., and Holers V.M. Lack of a functional alternative complement pathway ameliorates ischemic acute renal failure in mice. J. Immunol. 170 (2003) 1517-1523
326. Thurman J.M., Lucia M.S., Ljubanovic D., and Holers V.M. Acute tubular necrosis is characterized by activation of the alternative pathway of complement. Kidney Int. 67 (2005) 524-530
327. Tinjust D., Kergoat H., and Lovasik J.V. Neuroretinal function during mild systemic hypoxia. Aviat. Space Environ. Med. 73 (2002) 1189-1194
328. Tomany S.C., Cruickshanks K.J., Klein R., Klein B.E.K., and Knudtson M.D. Sunlight and the 10 year incidence of age-related maculopathy. Arch. Ophthalmol. 122 (2004) 750-757
329. Tomany S.C., Wang J.J., van Leeuwen R., et al. Risk factors for incident age-related macular degeneration: Pooled findings from three continents. Ophthalmology 111 (2004) 1280-1287
330. Vardi N., Zhang L., Payne J., and Sterling P. Evidence that different cation chloride cotransporters in retinal neurons opposite response to GABA. J. Neurosci. 20 (2000) 7657-7663
331. Vingerling J.R., Dielemans I., Bots M.L., Hofman A., Grobbee D.E., and de Jong P.T. Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study. Am. J. Epidemiol. 142 (1995) 404-409
332. Vingerling J.R., Dielemans I., Hofman A., Groebbe D.E., Hijmering M., Kramer C.F., and de Jong P.T. The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology 102 (1995) 205-210
333. Vingrys A.J., and Garner A. The effect of a moderate level of hypoxia on human color vision. Doc. Ophthalmol. 66 (1987) 171-185
334. Vogt A. Ueber zystoide Retinadegeneration und die begleitenden Liniennetze, und ueber die optischen Bedingungen der Sichtbarkeit der Zysten. Klin. Monatsbl. Augenheilkd 92 (1934) 743-747
335. Wachtmeister L. Oscillatory potentials in the retina: what do they reveal. Prog. Retin. Eye Res. 17 (1998) 485-521
336. Wald G. The receptors of human color vision. Science 145 (1964) 1007
337. Wan S., LeClerc J.L., and Vincent J.L. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest 112 (1997) 676-692
338. Wang J.J., Mitchell P., Rochtchina E., Tan A.G., Wong T.Y., and Klein R. Retinal vessel wall signs and the 5 year incidence of age related maculopathy: the Blue Mountain Eye Study. Br. J. Ophthalmol. 88 (2004) 104-109
339. Wangsa-Wirawan N.D., and Linsenmeier R.A. Retinal oxygen: fundamental and clinical aspects. Arch. Ophthalmol. 121 (2003) 547-557
340. Warburg O. Ueber die Klassifizierung tierischer Gewebe nach ihrem Stoffwechsel. Biochem. Z. 184 (1928) 484-488
341. Wegscheider B.J., Weger M., Renner W., Steinbrugger I., Maerz W., Mossboeck G., Temmel W., El-Shabrawi Y., Schmut O., Jahrbacher R., and Haas A. Association of complement factor H Y402H gene polymorphism with different subtypes of exudative age-related macular degeneration. Ophthalmology 114 (2007) 738-742
342. Wellard J., Lee D., Valter K., and Stone J. Photoreceptors in the rat retina are specifically vulnerable to both hypoxia and hyperoxia. Vis. Neurosci. 22 (2005) 501-507
343. Wise G.N., Dollery C.T., and Henkind P. The retinal circulation. The Retinal Circulation (1971), Harper and Row, New York 34-54
344. Witmer A.N., Vrensen G.F.J.M., Van Noorden C.J.F., and Schlingemann R.O. Vascular endothelial growth factors and angiogenesis in eye disease. Prog. Retin. Eye Res. 22 (2003) 1-29
345. Wong T.Y., Klein R., Sun C., Mitchell P., Couper D.J., Lai H., Hubbard L.D., Sharrett A.R., and Atherosclerosis Risk in Communities Study. Age-related macular degeneration and risk for stroke. Ann. Intern. Med. 145 (2006) 98-106
346. Wong T.Y., Liew G., and Mitchell P. Clinical update: new treatments for age-related macular degeneration. Lancet 370 (2007) 204-206
347. Wu L., Martínez-Castellanos M.A., Quiroz-Mercado H., Arevalo J.F., Berrocal M.H., Farah M.E., Maia M., Roca J.A., Rodriguez F.J., and for the Pan American Collaborative Retina Group (PACORES). Twelve-month safety of intravitreal injections of bevacizumab (Avastin(R)): results of the Pan-American Collaborative Retina Study Group (PACORES). Graefe's Arch. Clin. Exp. Ophthalmol. 246 (2008) 81-87
348. Yamamoto F., Clausen H., White T., Marken J., and Hakomori S. Molecular genetic basis of the histo-blood group ABO system. Nature 345 (1990) 229-233
349. Yamamoto S., Gouras P., and Lopez R. The focal cone electroretinogram. Vision Res. 35 (1995) 1641-1649
350. Yang Z., Stratton C., Francis P.J., Kleinman M.E., Tan P.L., et al. Toll-like receptor 3 and geographic atrophy in age-related macular degeneration. N. Engl. J. Med. (2008) Epub ahead of print
351. Yannuzzi L.A., Negrao S., IIda T., Carvalho C., Rodriguez-Coleman H., Freund K.B., Sorenson J., Orlock C.R.A., and Borodoker N. Retinal angiomatous proliferation. Retina 21 (2001) 416-434
352. Yarr M.T. Central chorioretinitis, resembling an optic disc, in a patient suffering from glucosuria. Trans. Am. Ophthalmol. Soc. UK 19 (1898-1899) 68-69
353. Young R.W. Pathophysiology of age-related macular degeneration. Surv. Ophthalmol. 31 (1987) 291-306
354. Yu D.-Y., and Cringle S. Oxygen distribution and consumption within the retina in vascularised and avascular retinas and in animal models of retinal disease. Prog. Retin. Eye Res. 20 (2001) 175-208
355. Yu D.-Y., and Cringle S. Outer retinal anoxia during dark adaptation is not a general property of mammalian retinas. Comp. Biochem. Phys. 132 (2002) 47-52
356. Zareparsi S., Branham K.E.H., Li M., Shah S., Klein R.J., Ott J., Hoh J., Abecasis G.R., and Swaroop A. Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration. Am. J. Hum. Genet. 77 (2005) 149-153
357. Zele, A.J., Cao, D., Pokorny, J., 2008. Rod-cone interactions and the temporal impulse response of the cone pathway. Vision Res. 48, 2593-2598.
358. Zele A.J., O'Loughlin R.K., Guymer R.H., and Vingrys A.J. Disclosing disease mechanisms with a spatio-temporal summation paradigm. Graefe's Arch. Clin. Exp. Ophthalmol. 244 (2006) 425-432
359. Zhao J., Frambach D., Lee P., Lee M., and Lopez P. Delayed macular choriocapillary circulation in age-related macular degeneration. Int. Ophthalmol. Clin. 19 (1995) 1-12